Search
for
Sort by
Research 30 of 182
- THE ENDOCRINE SYSTEM AND HAIR GROWTH IN THE RAT
- THE EFFECTS OF THE SYNTHETIC AND NATURAL HORMONE OF THE ADRENAL CORTEX ON MELANIN DEPOSITION IN ADRENALECTOMIZED BLACK RATS FED DIETS ADEQUATE AND DEFICIENT IN THE FILTRATE FACTORS OF VITAMIN B<sup>1</sup>
- Treatment of hyperandrogenism in women
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Hormonal Therapy for Acne
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Anti-androgen therapy in dermatology: a review
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Hair Loss in Women
- Hirsutism in the Adolescent Female
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Genetic Defects of Female Sexual Differentiation
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- An Update of Congenital Adrenal Hyperplasia
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Congenital Adrenal Hyperplasia
- Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Nonclassic Congenital Adrenal Hyperplasia
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Congenital adrenal hyperplasia
- Androgenetic alopecia; drug safety and therapeutic strategies
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats